Prognostic Impacts of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome Patients Without Heart Failure

Background: Despite the recommendations from mainstream guidelines, the use of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) for acute coronary syndrome (ACS) patients without heart failure (HF) is controversial, as its evidence is lacking in the era of repe...

Full description

Bibliographic Details
Main Authors: Chen, Runzhen, Liu, Chen, Zhou, Peng, Li, Jiannan, Zhou, Jinying, Wang, Ying, Zhao, Xiaoxiao, Chen, Yi, Yan, Shaodi, Song, Li, Zhao, Hanjun, Yan, Hongbing
Format: Online Article Text
Language:English
Published: Frontiers Media S.A. 2022
Subjects:
Pharmacology
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037138/
https://www.ncbi.nlm.nih.gov/pubmed/35479321
http://dx.doi.org/10.3389/fphar.2022.663811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9037138/
https://www.ncbi.nlm.nih.gov/pubmed/35479321
http://dx.doi.org/10.3389/fphar.2022.663811

Similar Items